MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'hedge funds'. Sat, 03 Sep 2011 02:38:01 +0100 http://www.medworm.com/index.php?rid=5062226&cid=t_121015_87_f&fid=36438&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FFGsoGrS2IEA%2F I’ve argued that the Dodd-Frank financial reform bill does not end “too-big-to-fail”, that is the belief that certain companies are implicitly backed by the government because policy-makers are unlikely to let said institutions actually fail. By naming some companies as ”systemically important” — as required by Dodd-Frank — the government is actually sending a signal as to who is likely to be bailed out. As evidenced by regulators’ behavior during the financial crisis, the prime beneficiaries would be the creditors of these companies, as even when shareholders and management suffered, creditors generally did not. This should allow such firms to borrow at a cost lower than firms not deemed systemically important. Given this funding... Cato-at-liberty blogs http://www.medworm.com/rss/comments.php?id=5062226 Mon, 25 Jul 2011 12:53:37 +0100 5062226 http://www.medworm.com/index.php?rid=4377789&cid=t_121015_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FaVe4cHW2HSM%2F In a move that some may consider long overdue, more than a dozen of the most prestigious medical journals will consider requiring doctors who submit studies to disclose any payments received from hedge funds and other large investors. The proposal is expected to be discussed at the next annual meeting of The International Committee of Medical Journal Editors, which is scheduled for June, according to a spokeswoman for the New England Journal of Medicine. The possibility follows ongoing concerns about conflicts of interest between researchers and the pharmaceutical industry and the extent to which undisclosed financial relationships may unduly influence medical research and, from there, medical practice. But the issue is also encompassing financial ties to large investors, given the growing... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4377789 Thu, 20 Jan 2011 15:21:05 +0100 4377789 http://www.medworm.com/index.php?rid=4318547&cid=t_121015_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fgi-3YqGN11Q%2F Those big payouts given pharma whistleblowers have attracted a new sort of attention - hedge funds. To wit, one fund manager believes these cases are attractive investment opportunities, given the huge sums that drugmakers have been paying the US Treasury to settle charges of off-label marketing and, more recently, manufacturing fraud (see this about GlaxoSmithKline). “The investment community is already looking at those kinds of opportunities,” David Desser, managing director of Juris Capital, a hedge fund that specializes in litigation finance, tells the the Royal Society of Chemistry’s ChemWorld. Essentially, this is a new class of assets that can be monetized and by, essentially, underwriting the whistleblower during the process, funds may receive big cuts. Here&#8217... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4318547 Thu, 06 Jan 2011 13:51:35 +0100 4318547 http://www.medworm.com/index.php?rid=4139479&cid=t_121015_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FtplnNqFKIZU%2F Nearly four years after raising a big stink - and filing a group of $4.6 billion lawsuits - over allegations that research analysts and hedge funds conspired to drive down its stock price, Biovail has finally given up. The white flag was raised, however, only after a recent merger with Valeant Pharmaceuticls that ushered in new management and a new way of viewing a dispute that generated significant publicity and aggravation, but not much else. And so Valeant has agreed to pay $10 million to SAC Capital Advisors to reimburse the hedge fund for the cost of defending two earlier actions filed by Biovail and its shareholders. Both suits against SAC, which is run by billionaire investor Steven Cohen, were dismissed. Moreover, the drugmaker has issued an apology, a rather rare omission, given t... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4139479 Fri, 05 Nov 2010 13:41:00 +0100 4139479 http://www.medworm.com/index.php?rid=2737696&cid=t_121015_87_f&fid=36438&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FyPNJcGHYRgM%2F A Bloomberg story on one cause of the ongoing British economic disaster under Prime Minister Gordon Brown: Andrew Wesbecher moved to London from New York in 2006 to sell software to banks and hedge funds. This month he joined the exodus of American expatriates fleeing high taxes and the city’s shrinking financial industry . . . Americans are heading home as Britain plans a 50 percent tax rate for those who earn more than 150,000 pounds ($248,000) a year and employers cut benefits for workers living abroad, reducing the allure of London. That comes a year after the U.K. said foreigners who have lived in the country for more than seven years must pay 30,000 pounds annually or give up the special status that shields overseas income from British taxes. Since the 1980s, London has boomed as a... Cato-at-liberty blogs http://www.medworm.com/rss/comments.php?id=2737696 Thu, 27 Aug 2009 13:30:19 +0100 2737696 http://www.medworm.com/index.php?rid=2347941&cid=t_121015_87_f&fid=34765&url=http%3A%2F%2Fhcrenewal.blogspot.com%2F2009%2F04%2Fhedge-fund-u-version-2.html We have posted frequently on the governance and leadership of academic medical organizations. While one would think that health care organizations, and especially academic health care organizations ought to be held to a particularly high standard of governance, we have noted how their governance is often unrepresentative of key constituencies, opaque, unaccountable, unsupportive of the academic and health care mission, and not subject to codes of ethics. How the governance of organizations with such exemplary missions and sterling repuations got this way has been unclear.In 2007, we reported on one famous institution which had a more representative, transparent, and accountable form of governance. Let me provide a summary of the background from FIRE, the Foundation for Individual Rights in... Health Care Renewal blogs http://www.medworm.com/rss/comments.php?id=2347941 Mon, 13 Apr 2009 18:18:00 +0100 2347941 http://www.medworm.com/index.php?rid=2347944&cid=t_121015_87_f&fid=34765&url=http%3A%2F%2Fhcrenewal.blogspot.com%2F2009%2F04%2Fhedge-fund-u.html We previously posted about how the Bernie Madoff scandal shed light on problems in the governance and leadership of one major university (which includes a well-known medical school). Yeshiva University, which includes the Albert Einstein College of Medicine, reportedly lost more than $11o million of its investments with Madoff. Not only was Madoff on the university's board of trustees, but also the chairman of the board's investment committee was hedge fund leader Ezra Merkin. Merkin invested the university's money in his own hedge funds, which, in turn, turned over the money to Madoff.This week, Merkin, who like Madoff has left the Yeshiva board, was charged with civil fraud. As reported by the Wall Street Journal,J. Ezra Merkin, a money manager who funneled $2.4 billion from universities... Health Care Renewal blogs http://www.medworm.com/rss/comments.php?id=2347944 Thu, 09 Apr 2009 18:59:00 +0100 2347944 http://www.medworm.com/index.php?rid=2306979&cid=t_121015_87_f&fid=34765&url=http%3A%2F%2Fhcrenewal.blogspot.com%2F2009%2F03%2Fhedging-future-of-fda.html A little while ago, we discussed the Obama administration's nomination for Commissioner of the US Food and Drug Administration (FDA), Dr Margaret Hamburg, focused on her current position as a director of Henry Schein Inc, a large distributor of medical products, including drugs and devices. There is another aspect of her nomination worthy of discussion, but which has not been publicly discussed. It has appeared almost as a footnote in a few reports of her nomination. For example, at the end of an article in the Chicago Tribune,Hamburg is married to Peter Fitzhugh Brown, an artificial intelligence expert who is executive vice president and director of Renaissance Technologies, a privately owned hedge fund. In this time of financial meltdown, hedge funds are more frequently mentioned in the ... Health Care Renewal blogs http://www.medworm.com/rss/comments.php?id=2306979 Mon, 30 Mar 2009 19:07:00 +0100 2306979 http://www.medworm.com/index.php?rid=637976&cid=t_121015_87_f&fid=34865&url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F05%2F24%2Fcancer-research-competition-could-fuel-better-research%2F Filed under: Research, EventsIf all else fails, why not hold a competition with a million dollar prize for the best cancer cure idea? This is exactly what a group of Harvard researchers and hedge fund managers are doing. Due to a recent lack of adequate federal funding, the Gotham Prize for Cancer Research has been formed to bring out the most creative ideas to help further cancer research. While more traditional folks might balk at an idea that focuses on creativity rather than concrete proof, the founders of the organization are expecting good things to come of the contest. The competitors will be invited to write an essay outlining their idea. Over the course of a year the entries will be evaluated and judged on their feasibility. This sounds like a most interesting approach.Read |... The Cancer Blog blogs http://www.medworm.com/rss/comments.php?id=637976 Thu, 24 May 2007 04:00:00 +0100 637976